Exposure of osteosarcoma cells to sub-lethal doses of doxorubicin upregulated Notch1 signaling and promoted the EMT, whereas treatment with GSI was able to prevent these changes [513]. This evidence concerns the gene NOTCH1 and osteosarcoma.